Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
PTC Therapeutics Inc
F:BH3
PTC Therapeutics Inc
F:BH3
Price:
55
EUR
2.04%
Market Closed
Market Cap:
€4.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
PTC Therapeutics Inc
F:BH3
|
US |
|
F
|
Ferrari NV
F:2FE
|
IT |
|
P
|
Performance Food Group Co
F:P5F
|
US |
|
L
|
Lockheed Martin Corp
XMUN:LOM
|
US |
|
Ralph Lauren Corp
NYSE:RL
|
US |
Wall St Price Targets
BH3 Price Forecast
Based on 17 analysts
Based on 17 analysts
+66% Upside
from
€55
today
PTC Therapeutics Inc (BH3)’s 12-month stock price forecast through September 2027 has a consensus target of €91.53, implying 66% upside. The forecast is based on price targets from 17 Wall Street analysts.
BH3 Analyst Rating
No ratings yet
No ratings yet
PTC Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BH3's stock price target?
Price Target
91.53
EUR
91.53
EUR
According to Wall Street analysts, the average 1-year price target for BH3 is 91.53 EUR with a low forecast of 61 EUR and a high forecast of 117.78 EUR.